Starting with Science: Navigating the Journey from Lab to Launch with Sean Macfarlane

Join Sean Macfarlane, Founder and CEO of Biomarx, for a raw look at the transition from academic research to high-stakes biotech entrepreneurship. A molecular and cellular biologist with a background in infectious diseases and automated platforms, Sean pivoted to tackle one of the most pressing challenges in medicine: lung cancer. In this episode, we explore the "why" and "how" of launching a startup before the MVP exists—navigating IP complications, securing pre-seed funding as a first-time founder, and leveraging the rapidly growing Irish tech ecosystem.🎯 Insights You’ll Learn:✓ The Pivot: Why IP and funding hurdles turned an academic project into a commercial startup✓ Raising on Vision: How to secure pre-seed investment with no MVP and no data✓ The Northern Ireland Advantage: Leveraging the Clarendon Co-Fund and InvestNI support✓ Solving for Lung Cancer: Why clinical care standards need a molecular revolution✓ From Industry to Innovation: Transitioning from infectious disease labs to method development✓ Accelerator Insights: Lessons from the Pioneer Group MedTech and Founders Lab programs✓ The 2026 Roadmap: Navigating regulatory milestones and prepping for a 2027 Seed raise🌍 Why This Matters:Lung cancer remains one of the world's most difficult medical challenges, with clinical care standards lagging behind the potential of modern molecular biology. Sean Macfarlane is proving that you don't need a finished product to begin the mission. By building a commercial vehicle first to secure the necessary capital, he is creating a pathway to move life-saving diagnostics out of the lab and into the clinics where they are needed most.👤 Expert Background:• Founder & CEO of Biomarx, a startup dedicated to advanced cancer diagnostics• Molecular and Cellular Biologist with deep expertise in automated molecular platforms• Specialist in infectious disease diagnostics with extensive experience in CRO and clinical labs• Alumnus of the Pioneer Group MedTech Accelerator and InvestNI Founders Lab• Visionary leader focused on method development and improving lung cancer survival rates🎙️ Hosted by Gary Fowler, CEO of GSD Venture Studios — global AI entrepreneur, investor, and innovation leader spotlighting founders navigating the realities of building in the AI era.💡 Perfect For:First-time founders, biotech investors, medical researchers, university students interested in commercialization, and anyone navigating the Northern Ireland and Irish startup ecosystems.🚀 Timely Topic:As the barrier between academia and industry blurs, the next generation of medical breakthroughs will come from founders who can bridge the gap between complex science and the realities of venture capital and regulatory compliance.Subscribe for more global founder conversations from GSD Venture Studios:👉 GSD Venture Studios: https://gsdvs.com#Biotech #CancerDiagnostics #StartupJourney #NorthernIrelandTech #MedTech #VentureCapital #MolecularBiology #SeanMacfarlane #GaryFowler #GSDVentureStudios